Concepedia

Phase 1 trial of ralimetinib (LY2228820) with radiotherapy plus concomitant temozolomide in the treatment of newly diagnosed glioblastoma

J. Biau, Émilie Thivat, Emmanuel Chautard, D. Stefan, M.M. Boone, Bruno Chauffert, Céline Bourgne, Daniel Richard, Ioana Molnar, Sarah Lévesque,

Radiotherapy and Oncology · 2020 · 39 citations · 30 references

DOIFull text

Open access

Concepts

References

30

Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma

Roger Stupp, Warren Mason, Martin J. van den Bent et al. · New England Journal of Medicine · 2005 · 21.6K citations · Full text

, , +12

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

Roger Stupp, Monika E. Hegi, Warren Mason et al. · The Lancet Oncology · 2009 · 7.8K citations

, , +17

Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group

Patrick Y. Wen, David R. Macdonald, David A. Reardon et al. · Journal of Clinical Oncology · 2010 · 3.8K citations · Full text

, , +15

Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial

Wolfgang Wick, Michael Platten, Christoph Meisner et al. · The Lancet Oncology · 2012 · 1.1K citations · Full text

, , +14

Sequential Designs for Phase I Clinical Trials with Late‐Onset Toxicities

Ying Kuen Cheung, Rick Chappell · Biometrics · 2000 · 534 citations

, , +13